ÂÜÀòÂÒÂ×

Hugh Fryer is Vice President of Research and Development for GestVision, Inc.

With more than 30 years of experience in research and management related to clinical therapeutics and diagnostics, Hugh has held positions at Sekisui Diagnostics, American Diagnostica, and Curagen Corporation as a strategic leader responsible for developing new product portfolio pipelines. He has been responsible for leading R&D sites both here in the United States and overseas.

He holds a Ph.D. from Yale University and a BS from the University of California San Diego.